Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.12.2022 | Case report

Antineoplastics

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Saito A, et al. Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant. Cancer Treatment and Research Communications 32: Jan 2022. Available from: URL: http://doi.org/10.1016/j.ctarc.2022.100587 Saito A, et al. Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant. Cancer Treatment and Research Communications 32: Jan 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​ctarc.​2022.​100587
Metadaten
Titel
Antineoplastics
Lack of efficacy: case report
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-28863-2

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Quetiapine

Case report

Methotrexate

Case report

Multiple drugs

Case report

Tozinameran